The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

President Trump signed an order to reschedule marijuana to a lower drug classification, one of the most significant changes ...

For the first time, traditional drug spending has exceeded specialty drug spending, largely due to the demand for GLP-1s, according to a new report from Evernorth Research Institute. Evernorth ...

Demand for GLP-1 drugs is causing spending on traditional drugs to grow at a faster clip than spending on specialty drugs, according to new research. That could put further stress on employers and ...

Scientists at the University of Lausanne (UNIL) and University center Unisanté classified 35 commonly used drugs in Switzerland based on their impact on the aquatic biodiversity. Scientists at the ...